FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to therapy and gastroenterology. Clinical symptoms and risk factors are determined from life anamnesis: heartburn frequency, presence of night heartburn, methods of heartburn relief, intensity of constipation, presence of diseases of pancreatobiliary zone, tobacco-smoking, regular intake of alcohol, episodes of intake of non-steroid anti-inflammatory preparations. Their gradations and numerical values are found, after which prognostic coefficients are calculated.
EFFECT: basing on comparison of the calculated prognostic coefficients high, low or medium risk of possibility of developing severe forms of gastroesophageal reflux disease (GERD) is predicted.
1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREDICTING UNFAVOURABLE COURSE OF GASTROESOPHAGEAL REFLUX DISEASE | 2009 |
|
RU2407447C1 |
| PREDICTION METHOD OF GASTROESOPHAGEAL REFLUX DISEASE SEVERITY | 2015 |
|
RU2620546C1 |
| METHOD FOR PREDICTION OF CLINICAL COURSE OF GASTROESOPHAGEAL REFLUX DISEASE | 2012 |
|
RU2530634C2 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN PATIENTS AT NO SIGNS OF BRONCHIAL OBSTRUCTION | 2005 |
|
RU2303956C1 |
| METHOD OF PREDICTING CLINICAL COURSE OF COGNITIVE IMPAIRMENT IN PATIENTS WITH ISCHEMIC STROKE | 2009 |
|
RU2405450C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING GASTROESOPHAGEAL REFLUX DISEASE | 2012 |
|
RU2501549C1 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN SMOKING PERSONS | 2005 |
|
RU2303957C1 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF DISORDERS OF REPARATIVE OSSEOUS REGENERATION AND SURROUNDING SOFT TISSUES IN PATIENTS WITH MOTOR APPARATUS DISEASES | 2005 |
|
RU2300316C2 |
| METHOD FOR PREDICTION OF CHRONIC CEREBRAL ISCHAEMIA DEVELOPMENT IN MEN WITH LIGHT AND MODERATE CHRONIC OBSTRUCTIVE LUNGS DISEASE WITHOUT CLINICAL IMPLICATIONS OF CEREBROVASCULAR PATHOLOGY | 2007 |
|
RU2347521C1 |
| METHOD FOR PREDICTING DYSCIRCULATORY ENCEPHALOPATHY DEVELOPMENT COURSE IN BRONCHIAL ASTHMA PATIENTS WITH NO MANIFESTATIONS OF CEREBRAL VASCULAR PATHOLOGY | 1999 |
|
RU2171626C2 |
